远大医药(00512.HK)创新成果再亮相 核药抗肿瘤诊疗优势地位显著 Go Global战略夯实核药MNC领军地位

智通财经
Aug 26
【远大医药(00512.HK)创新成果再亮相 核药抗肿瘤诊疗优势地位显著 Go Global战略夯实核药MNC领军地位】智通财经APP获悉,近日,浦江泌尿肿瘤学术大会暨上海市抗癌协会泌尿肿瘤专委会年会在上海举行,国内外泌尿肿瘤领域顶尖专家齐聚一堂,远大医药(00512.HK)在会上重磅发布“尿路上皮癌早筛早诊项目”,并带来专题报告《尿路上皮癌精准诊疗与泌尿肿瘤核药研发进展》,集中展示公司在早筛早诊、精准诊疗与核药创新的系统布局与科研实力。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10